Appropriate patient selection is critical to maximizing benefit and minimizing side-effects of the SIRT procedure. SIR-Spheres® Y-90 resin microspheres should be used in unresectable liver cancer patients with:
- Liver-dominant or liver-only disease;
- Good performance status (ECOG/WHO PS 0-2)
- Life expectancy > 3 months
- Adequate liver function (bilirubin <34 μmol/L or 2.0 mg/dL)